We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 10,000 results
  1. Role of gut microbiota in the pathogenesis of castration-resistant prostate cancer: a comprehensive study using sequencing and animal models

    CRPC remains a significant challenge in prostate cancer research. We aimed to elucidate the role of gut microbiota and its specific mechanisms in...

    Guowen Lin, Feng Zhang, ... Gangmin Wang in Oncogene
    Article 17 June 2024
  2. Impact of structural biology and the protein data bank on us fda new drug approvals of low molecular weight antineoplastic agents 2019–2023

    Open access to three-dimensional atomic-level biostructure information from the Protein Data Bank (PDB) facilitated discovery/development of 100% of...

    Stephen K. Burley, Amy Wu-Wu, ... Steven X. F. Zheng in Oncogene
    Article Open access 17 June 2024
  3. Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia

    The age effect in severe aplastic anemia (SAA) following allogeneic hematopoietic cell transplantation (HCT) favors the use of reduced intensity...

    Rachel M. Gilmore, Karin Abernathy, ... Katie Gatwood in Bone Marrow Transplantation
    Article Open access 15 June 2024
  4. METTL3-mediated N6-methyladenosine modification of STAT5A promotes gastric cancer progression by regulating KLF4

    N 6 -methyladenosine (m 6 A) is the predominant post-transcriptional RNA modification in eukaryotes and plays a pivotal regulatory role in various...

    Yichen Zang, Zhuangfei Tian, ... Zhifang Liu in Oncogene
    Article Open access 15 June 2024
  5. Environmental monobutyl phthalate exposure promotes liver cancer via reprogrammed cholesterol metabolism and activation of the IRE1α-XBP1s pathway

    Humans are widely exposed to phthalates, a major chemical plasticizer that accumulates in the liver. However, little is known about the impact of...

    Tingting Zhang, Faming Zhao, ... **a Sheng in Oncogene
    Article 15 June 2024
  6. Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study

    This multicentre, two-arm, phase 2 study aimed to explore the efficacy and safety of neoadjuvant camrelizumab plus chemotherapy or apatinib in...

    Haoran **a, Han Zhang, ... Gening Jiang in Signal Transduction and Targeted Therapy
    Article Open access 14 June 2024
  7. Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation

    We retrospectively analyzed high-risk ALL patients in CR1 receiving total body irradiation based conditioning regimen with ATLG ( n  = 74) or PTCy ( n =...

    Normann Steiner, Radwan Massoud, ... Nicolaus Kröger in Bone Marrow Transplantation
    Article Open access 14 June 2024
  8. Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer

    Treatment-induced neuroendocrine prostate cancer (t-NEPC) often arises from adenocarcinoma via lineage plasticity in response to androgen receptor...

    Bo Chen, Pengfei Xu, ... Chengfei Liu in Oncogene
    Article 14 June 2024
  9. Activated platelet-derived exosomal LRG1 promotes multiple myeloma cell growth

    The hypercoagulable state is a hallmark for patients with multiple myeloma (MM) and is associated with disease progression. Activated platelets...

    Meng Gao, Hang Dong, ... Yanwei Luo in Oncogenesis
    Article Open access 13 June 2024
  10. Disparities in access to hematopoietic cell transplant persist at a transplant center

    Disparities in access to hematopoietic cell transplant (HCT) are well established. Prior studies have identified barriers, such as referral and...

    Jamie Shoag, Seth J. Rotz, ... Betty K. Hamilton in Bone Marrow Transplantation
    Article Open access 13 June 2024
  11. Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes

    Breast cancer (BC) is a leading cause of cancer-related death worldwide. The diverse nature and heterogeneous biology of BC pose challenges for...

    Abhibhav Sharma, Julia Debik, ... Guro F. Giskeødegård in Oncogenesis
    Article Open access 13 June 2024
  12. Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer

    Cell membrane-camouflaged nanoparticles possess inherent advantages derived from their membrane structure and surface antigens, including prolonged...

    Yun Yang, Qingya Liu, ... Zhiyong Qian in Signal Transduction and Targeted Therapy
    Article Open access 12 June 2024
  13. Efficient bone marrow irradiation and low uptake by non-haematological organs with an yttrium-90-anti-CD66 antibody prior to haematopoietic stem cell transplantation

    We report the results of a Phase I radiation dose escalation study using an yttrium-90 ( 90 Y) labelled anti-CD66 monoclonal antibody given with...

    Kim Orchard, Jonathan Langford, ... Valerie Lewington in Bone Marrow Transplantation
    Article Open access 12 June 2024
  14. Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents

    The herd immunity against SARS-CoV-2 is continuously consolidated across the world during the ongoing pandemic. However, the potential function of...

    **n Wang, Jie Zhang, ... Jun Liu in Signal Transduction and Targeted Therapy
    Article Open access 12 June 2024
Did you find what you were looking for? Share feedback.